Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

A new study has found intermittent fasting could slow, or even reverse, the progression of Alzheimer’s disease.

Intermittent fasting may be the key to slowing or even reversing the signs of Alzheimer's disease, a new study suggests.

The first drug proven to slow down Alzheimer's won't be available to dementia patients in Scotland - unless they pay £60,000 ...

Diabetes is a common, lifelong condition that occurs when the pancreas doesn't produce enough insulin, or when the body is unable to effectively use the insulin it produces ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers cellular inflammation and aging and is linked to Alzheimer's disease, ...

A recent study published in eLife offers a new perspective on the development of Alzheimer’s disease, suggesting that the ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Their findings showed "positive associations" between Vitamin D deficiency and an increased risk of dementia (by 32 per cent) ...

The concept of a cognitive reserve is linked to lowering the risk of diseases such as Alzheimer's, Parkinson's, MS or having ...

Joe is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...